Sign in
Analysis for Genetic Modifiers of Disease Severity in Patients With Long-QT Syndrome Type 2
Journal article   Open access

Analysis for Genetic Modifiers of Disease Severity in Patients With Long-QT Syndrome Type 2

Iris C R M Kolder, Michael W T Tanck, Pieter G Postema, Julien Barc, Moritz F Sinner, Sven Zumhagen, Anja Husemann, Birgit Stallmeyer, Tamara T Koopmann, Nynke Hofman, …
Circulation. Cardiovascular genetics, Vol.8(3), pp.447-456
2015-06
PMCID: PMC4770255
PMID: 25737393

Abstract

Severity of Illness Index Genome-Wide Association Study KCNQ1 Potassium Channel - genetics Humans Risk Factors Genotype Male Long QT Syndrome - pathology Case-Control Studies Adaptor Proteins, Signal Transducing - genetics Alleles Electrocardiography Long QT Syndrome - genetics Female Polymorphism, Single Nucleotide Long QT Syndrome - drug therapy Odds Ratio Adrenergic beta-Antagonists - therapeutic use
url
https://doi.org/10.1161/CIRCGENETICS.114.000785View
Published (Version of record) Open

InCites Highlights

These are selected metrics from InCites Benchmarking & Analytics tool, related to this output

Collaboration types
Domestic collaboration
International collaboration
Citation topics
1 Clinical & Life Sciences
1.94 Cardiac Arrhythmia
1.94.470 Brugada Syndrome
Web Of Science research areas
Cardiac & Cardiovascular Systems
Genetics & Heredity
ESI research areas
Molecular Biology & Genetics

UN Sustainable Development Goals (SDGs)

This output has contributed to the advancement of the following goals:

#3 Good Health and Well-Being

Source: InCites

Details